0000899243-20-018613.txt : 20200707 0000899243-20-018613.hdr.sgml : 20200707 20200707131255 ACCESSION NUMBER: 0000899243-20-018613 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200702 FILED AS OF DATE: 20200707 DATE AS OF CHANGE: 20200707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mass Robert D. CENTRAL INDEX KEY: 0001522224 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50484 FILM NUMBER: 201015789 MAIL ADDRESS: STREET 1: C/O MARSHALL EDWARDS, INC. STREET 2: 11975 EL CAMINO REAL, SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEI Pharma, Inc. CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-369-7100 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MARSHALL EDWARDS INC DATE OF NAME CHANGE: 20030902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-02 0 0001262104 MEI Pharma, Inc. MEIP 0001522224 Mass Robert D. C/O MEI PHARMA, INC. 11455 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 3.49 2020-07-02 4 A 0 230000 0.00 A 2030-07-02 Common Stock 230000 230000 D Stock Option (Right to Buy) 1.57 2025-07-28 Common Stock 112500 112500 D Stock Option (Right to Buy) 1.36 2026-07-29 Common Stock 135000 135000 D Stock Option (Right to Buy) 2.83 2027-07-06 Common Stock 135000 135000 D Stock Option (Right to Buy) 4.33 2028-06-22 Common Stock 100000 100000 D Stock Option (Right to Buy) 4.28 2028-07-12 Common Stock 130000 130000 D Stock Option (Right to Buy) 2.52 2029-07-01 Common Stock 230000 230000 D One-quarter of such options shall vest on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021. All of such options are presently exercisable. One-quarter of such options vested on July 29, 2017 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 29, 2017. One-quarter of such options vested on July 6, 2018 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 6, 2018. One-quarter of such options vested on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019. One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019. One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020. /s/ Brian G. Drazba, as attorney in fact 2020-07-02